Norditropin Nordiflex



Indications and Reactions:

Role Indications Reactions
Primary
Growth Hormone Deficiency 23.8%
Drug Use For Unknown Indication 16.4%
Haemodialysis 10.7%
Product Used For Unknown Indication 9.4%
Hypertension 5.6%
Body Height Below Normal 5.4%
Asthma 3.3%
Ill-defined Disorder 3.1%
Hypopituitarism 2.9%
Prophylaxis 2.8%
Hypothyroidism 2.6%
Rheumatoid Arthritis 1.9%
Diabetes Insipidus 1.8%
Type 2 Diabetes Mellitus 1.7%
Growth Retardation 1.5%
Hypersensitivity 1.5%
Blood Cholesterol Increased 1.4%
Cough 1.4%
Cushing's Syndrome 1.4%
Insulin Resistance 1.4%
Craniopharyngioma 7.0%
Death 7.0%
Vomiting 7.0%
Tonsillar Hypertrophy 6.2%
Urinary Tract Infection 6.2%
Hyperglycaemia 5.4%
Azotaemia 4.7%
Gastrointestinal Haemorrhage 4.7%
Haemoptysis 4.7%
Malignant Melanoma 4.7%
Myocardial Infarction 4.7%
Papilloedema 4.7%
Retinal Detachment 4.7%
Sleep Apnoea Syndrome 4.7%
Type 1 Diabetes Mellitus 4.7%
Blood Glucose Increased 3.9%
Chest Pain 3.9%
Convulsion 3.9%
Haemorrhage Intracranial 3.9%
Osteonecrosis 3.9%
Secondary
Growth Hormone Deficiency 17.5%
Product Used For Unknown Indication 12.8%
Haemodialysis 9.5%
Chondrodystrophy 6.2%
Body Height Below Normal 5.9%
Hypertension 5.9%
Hypopituitarism 5.9%
Hypothyroidism 4.7%
Convulsion 3.9%
Drug Use For Unknown Indication 3.9%
Cardiac Failure 3.0%
Diabetes Mellitus 2.7%
Fatigue 2.7%
Prophylaxis 2.7%
Renal Failure Chronic 2.7%
Diarrhoea 2.4%
Diabetes Insipidus 2.1%
Hypersensitivity 2.1%
Hyperphosphataemia 1.8%
Weight Increased 1.8%
Condition Aggravated 11.5%
Sleep Apnoea Syndrome 8.7%
Death 6.7%
Syncope 6.7%
Craniopharyngioma 5.8%
Transient Ischaemic Attack 5.8%
Urinary Tract Infection 5.8%
Weight Decreased 5.8%
Hyperglycaemia 4.8%
Blood Glucose Increased 3.8%
Convulsion 3.8%
Empty Sella Syndrome 3.8%
Myocardial Infarction 3.8%
Papilloedema 3.8%
Pneumonia 3.8%
Transaminases Increased 3.8%
Diarrhoea 2.9%
Stevens-johnson Syndrome 2.9%
Type 1 Diabetes Mellitus 2.9%
Vomiting 2.9%
Concomitant
Hypopituitarism 36.4%
Prophylaxis 36.4%
Osteogenesis Imperfecta 18.2%
Pyrexia 9.1%
Vision Blurred 100.0%